Join thousands of others who rely on our journalism to navigate complex issues, uncover hidden truths, and challenge the status quo with our free newsletter, delivered straight to your inbox twice a week:

Join thousands of others who support our nonprofit journalism and help us deliver the news and analysis you won’t get anywhere else:

TRNN confronted the head of the country’s only prescription affordability board about his past ties to a lobbying firm that represented a major pharmaceutical company. It’s part of our ongoing coverage of the nation’s overpriced and ineffective healthcare industry.